Regeneron Pharmaceuticals
REGN
REGN
1,281 hedge funds and large institutions have $58.4B invested in Regeneron Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 140 funds opening new positions, 523 increasing their positions, 449 reducing their positions, and 148 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
5% less first-time investments, than exits
New positions opened: 140 | Existing positions closed: 148
2% less funds holding
Funds holding: 1,309 → 1,281 (-28)
12% less capital invested
Capital invested by funds: $66.5B → $58.4B (-$8.17B)
Holders
1,281
Holding in Top 10
15
Calls
$974M
Puts
$1B
Top Buyers
| 1 | +$351M | |
| 2 | +$248M | |
| 3 | +$214M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$193M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$166M |
Top Sellers
| 1 | -$889M | |
| 2 | -$533M | |
| 3 | -$474M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$381M |
| 5 |
Morgan Stanley
New York
|
-$114M |